Comparison of Approaches for Measuring Adherence and Persistence to Oral Oncologic Therapies in Patients Diagnosed with Metastatic Renal Cell Carcinoma.
Danielle S ChunBlánaid M HicksSharon Peacock HintonMichele Jonsson FunkKyna GoodenAlexander P KeilHung-Jui TanTil StürmerJennifer L LundPublished in: Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology (2022)
Use of several approaches can provide a more comprehensive picture of medication-taking behavior in the metastatic setting where death is a major competing risk.
Keyphrases
- end stage renal disease
- metastatic renal cell carcinoma
- ejection fraction
- chronic kidney disease
- newly diagnosed
- squamous cell carcinoma
- small cell lung cancer
- peritoneal dialysis
- prognostic factors
- healthcare
- prostate cancer
- emergency department
- type diabetes
- metabolic syndrome
- patient reported outcomes
- adverse drug
- robot assisted
- weight loss